Jurnal Ilmu Kefarmasian Indonesia
Vol 11 No 2 (2013): JIFI

3,3’-Di(5,7-dibromoindol-3-il)-indolin-2-on: Sintesis dan Uji Sitotoksik terhadap Sel Kanker Kolon WiDr

KAMILIA MUSTIKASARI (UNIVERSITAS LAMBUNGMANGKURAT)
MARDI SANTOSO (INSTITUT TEKNOLOGI SEPULUH NOPEMBER)

Article Info

Publish Date
30 Sep 2013

Abstract

Colon cancer is one of the causes of death in the world of concern, because until now there has not been found specific drug for its treatment. Therefore, the study aimed to synthesize compounds that have the potential as a novel anticancer compound derivative such as 3,3’-di (indol-3-yl) indolin-2-one is required. Synthesis was done by reacting 5,7-dibromoindole and isatin in methanol with an acid catalyst to produce 3,3’-di (5,7-dibromoindol-3-yl)-indolin-2-one compound with a yield of 48%. 3,3 ‘-di (5,7-dibromoindol-3-yl)-indolin-2-one is cytotoxic against colon cancer cell line WiDr with IC50 of 6.64 μM.

Copyrights © 2013




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Full PDF
320.279 KB
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
Jurnal Ilmu Kefarmasian Indonesia
Website

Abbrev

jifi

Publisher

Universitas Pancasila

Subject

Biochemistry, Genetics & Molecular Biology Health Professions Medicine & Pharmacology Public Health

Description

Jurnal Ilmu Kefarmasian Indonesia (JIFI) mainly focuses on a current topic in Pharmaceutical Sciences are also considered for publication by the Journal. Discussions on a topic in Pharmaceutical Sciences, Clinical Sciences, and Social Behaviour Administration. Detailed scopes of articles accepted ...